Clin2
NCT06815991Possibly a fitRecruiting

Testing a new supplement in healthy adults

Healthy Adults

This trial tests a new supplement called MIB-725, given as a single dose to see how safe it is and how the body handles it. Healthy adults aged 19 to 60 who don't smoke and are not on certain medications may join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
32 people
Ages
19 years to 60 years
Study type
Interventional

Who can take part

  • You are between 19 and 60 years old
  • You do not smoke cigarettes
  • Your body mass index (BMI) is between 19 and 37.5
  • You are generally healthy and not taking certain medications or supplements
  • You are willing to avoid alcohol and not take other supplements during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06745297Recruiting· Phase 1
Testing a new medicine in healthy men for safety

This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.

Berlin
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah
NCT07065136Not yet recruiting· Phase 1
Testing a new medicine in healthy adults

This trial tests a new medicine (called 627) in healthy adults to see if it is safe and how the body handles it. It may help future treatment development.

NCT07662148Recruiting· Phase 1
Testing the safety of BIIB144 in healthy adults

This trial tests a single dose of an experimental drug (BIIB144) in healthy adults to see if it is safe and how the body handles it. You would receive either the drug or a placebo (inactive shot) and be closely monitored.

Las Vegas, Nevada
NCT07797855Recruiting· Phase 1
Testing a new medicine's safety in healthy people

This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.

Groningen
NCT07235163Recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.

Brussels, Bruxelles-capitale, Région de

Hear when a new Healthy Adults trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.